Novel risk factors include increased inflammatory markers such as C-reactive protein, fibrinogen, and plasma homocysteine [25]. Hyperhomocysteinemia is also an independent risk factor for PAD [26]. This evidence concerns the gene CRP and peripheral arterial disease.